View Older Stories View More Recent Stories

Mar 17, 2021 04:05PM Adaptive Biotechnologies Strengthens Expertise and Diversity of Board of Directors with Appointments of Leslie Trigg and Katey Owen
Mar 5, 2021 06:44PM Adaptive Biotechnologies Announces FDA Emergency Use Authorization for T-Detect™ COVID to Confirm Recent or Prior COVID-19 Infection
Mar 5, 2021 06:44PM Adaptive Biotechnologies Announces FDA Emergency Use Authorization for T-Detect™ COVID to Confirm Recent or Prior COVID-19 Infection
Feb 26, 2021 07:11AM Cathie Wood's ARK Adds ~1.7M Shares of Twitter (TWTR), Sells Apple (AAPL), Alibaba (BABA)
Feb 23, 2021 09:15AM Adaptive Biotechnologies Expands Collaboration with Labcorp to Increase Access to Growing Research and Clinical Diagnostic Portfolio
Feb 23, 2021 09:15AM Adaptive Biotechnologies Expands Collaboration with Labcorp to Increase Access to Growing Research and Clinical Diagnostic Portfolio
Feb 23, 2021 07:39AM Adaptive Biotechnologies (ADPT) Launches T-Detect COVID, First Clinical T-Cell Based Test for Patients to Confirm Recent or Prior COVID-19 Infection
Feb 23, 2021 07:30AM Adaptive Biotechnologies Launches T-Detect™ COVID, First Clinical T-Cell Based Test for Patients to Confirm Recent or Prior COVID-19 Infection
Feb 23, 2021 07:30AM Adaptive Biotechnologies Launches T-Detect™ COVID, First Clinical T-Cell Based Test for Patients to Confirm Recent or Prior COVID-19 Infection
Jan 11, 2021 04:13PM Adaptive Biotechnologies (ADPT) to Collaborate with AstraZeneca (AZN) in Mapping the Immune Response to Cancer Antigens to Potentially Inform the Development of Novel Diagnostics and Therapeutics
Jan 11, 2021 04:01PM Adaptive Biotechnologies to Collaborate with AstraZeneca in Mapping the Immune Response to Cancer Antigens to Potentially Inform the Development of Novel Diagnostics and Therapeutics
Jan 11, 2021 04:01PM Adaptive Biotechnologies to Collaborate with AstraZeneca in Mapping the Immune Response to Cancer Antigens to Potentially Inform the Development of Novel Diagnostics and Therapeutics
Dec 6, 2020 10:00AM Adaptive Biotechnologies Announces New Clinical Data Demonstrating Impact of clonoSEQ® Assay on Patients with Blood Cancers at the 62nd ASH Annual Meeting
Dec 6, 2020 10:00AM Adaptive Biotechnologies Announces New Clinical Data Demonstrating Impact of clonoSEQ® Assay on Patients with Blood Cancers at the 62nd ASH Annual Meeting
Nov 23, 2020 08:00AM Adaptive Biotechnologies and Collaborators to Present Data from More Than 35 Abstracts at ASH 2020 Highlighting Clinical Relevance of MRD Testing with the clonoSEQ® Assay in Blood Cancer Patients
Nov 23, 2020 08:00AM Adaptive Biotechnologies and Collaborators to Present Data from More Than 35 Abstracts at ASH 2020 Highlighting Clinical Relevance of MRD Testing with the clonoSEQ® Assay in Blood Cancer Patients
Nov 13, 2020 08:02AM Adaptive Biotechnologies (ADPT) Announces Preliminary Data from Real-World Study Demonstrate T-cell Testing Outperforms Antibody Testing in Identifying Past SARS-CoV-2 Infections
Nov 13, 2020 08:00AM Preliminary Data from Real-World Study Demonstrate T-cell Testing Outperforms Antibody Testing in Identifying Past SARS-CoV-2 Infections
Nov 13, 2020 08:00AM Preliminary Data from Real-World Study Demonstrate T-cell Testing Outperforms Antibody Testing in Identifying Past SARS-CoV-2 Infections
Nov 10, 2020 04:19PM Adaptive Biotechnologies (ADPT) Enters Collaboration with GSK for clonoSEQ Assay
Nov 10, 2020 04:13PM Adaptive Biotechnologies Announces Collaboration with GSK to Measure Minimal Residual Disease with clonoSEQ® Assay Across its Hematology and Oncology Portfolio
Nov 10, 2020 04:12PM Adaptive Biotechnologies Announces Collaboration with GSK to Measure Minimal Residual Disease with clonoSEQ® Assay Across its Hematology and Oncology Portfolio
Aug 10, 2020 08:05AM Adaptive Biotechnologies to Present at the UBS Genomics 2.0 and Medtech Innovations Summit
Aug 10, 2020 08:05AM Adaptive Biotechnologies to Present at the UBS Genomics 2.0 and Medtech Innovations Summit
Aug 6, 2020 09:24AM Adaptive Biotechnologies Receives Expanded FDA Clearance for the clonoSEQ® Assay to Assess Minimal Residual Disease (MRD) in Patients with Chronic Lymphocytic Leukemia
Aug 6, 2020 09:24AM Adaptive Biotechnologies Receives Expanded FDA Clearance for the clonoSEQ® Assay to Assess Minimal Residual Disease (MRD) in Patients with Chronic Lymphocytic Leukemia
Aug 4, 2020 09:30AM Adaptive Biotechnologies Launches immunoSEQ T-MAP COVID, First Molecular T Cell Monitoring Tool for SARS-CoV-2
Jul 28, 2020 06:04PM Adaptive Biotechnologies Launches National Clinical Trial to Develop Novel T-Cell Based Diagnostic for Lyme Disease
Jul 28, 2020 06:04PM Adaptive Biotechnologies Launches National Clinical Trial to Develop Novel T-Cell Based Diagnostic for Lyme Disease
Jul 9, 2020 08:05AM Adaptive Biotechnologies to Report Second Quarter Financial Results on August 10, 2020
Jul 9, 2020 08:05AM Adaptive Biotechnologies to Report Second Quarter Financial Results on August 10, 2020
Jun 11, 2020 09:00AM Adaptive Biotechnologies and Microsoft launch groundbreaking ImmuneCODE database to share populationwide immune response to the COVID-19 virus
Jun 8, 2020 04:03PM UPDATE – Adaptive Biotechnologies to Participate in Upcoming June Investor Conferences
Jun 8, 2020 04:03PM UPDATE – Adaptive Biotechnologies to Participate in Upcoming June Investor Conferences
May 27, 2020 04:03PM Adaptive Biotechnologies to Participate in Upcoming June Investor Conferences
May 27, 2020 04:03PM Adaptive Biotechnologies to Participate in Upcoming June Investor Conferences
May 6, 2020 08:00AM Adaptive Biotechnologies to Present at the BofA Securities 2020 Healthcare Conference
May 6, 2020 08:00AM Adaptive Biotechnologies to Present at the BofA Securities 2020 Healthcare Conference
May 5, 2020 12:03PM Adaptive Biotechnologies (ADPT), Microsoft (MSFT) Launch Virtual ImmuneRACE Study on COVID-19
May 5, 2020 12:00PM Adaptive Biotechnologies and Microsoft launch virtual ImmuneRACE study to inform novel COVID-19 diagnostics to address unmet needs in testing
Apr 27, 2020 04:03PM Adaptive Biotechnologies to Report First Quarter Financial Results on May 12, 2020
Apr 27, 2020 04:03PM Adaptive Biotechnologies to Report First Quarter Financial Results on May 12, 2020
Apr 7, 2020 08:35PM Amgen And Adaptive Biotechnologies To Participate In Webinar On COVID-19 Strategic Collaboration
Apr 2, 2020 09:14AM Amgen (AMGN), Adaptive Biotechnologies (ADPT) Announce Strategic Partnership To Develop A Therapeutic To Prevent Or Treat COVID-19
Apr 2, 2020 09:00AM Amgen And Adaptive Biotechnologies Announce Strategic Partnership To Develop A Therapeutic To Prevent Or Treat COVID-19
Sep 18, 2019 01:00PM Divide & Conquer, Developing New Class of Cancer Therapeutics to Disrupt Cell-to-Cell Communication, Emerges from Stealth as New Paper by Co-Founder is Published in Nature
Jun 27, 2019 07:00AM Adaptive Biotechnologies Corporation (Nasdaq: ADPT) to Ring The Nasdaq Stock Market Opening Bell
Nov 26, 2015 07:33PM INVESTOR ALERT: Goldberg Law PC Announces an Ongoing Investigation of Claims against Adeptus Health Inc. and Encourages Shareholders to Contact the Firm
Nov 17, 2015 06:51PM IMPORTANT SHAREHOLDER NOTICE: Goldberg Law PC Announces an Ongoing Investigation of Claims against Adeptus Health Inc. and Encourages Shareholders to Contact the Firm
Sep 3, 2015 07:00AM Ochsner Health System and Adeptus Health Partner to Enhance Emergency Medical Care in Louisiana
View More Recent Stories View Older Stories